Therefore, our finding that GLUT2 may affect the potential mechanism underlying GlcN action in Hepa1-6 cells could herald a new therapeutic approach that utilizes the unique metabolism of HCC. Here, SLC2A2 is linked to hepatocellular carcinoma.